LY-256548

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameLY-256548
Drug Alias NameLY-256548
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhospholipase A2 group IIA inhibitorsArachidonate 5-lipoxygenase inhibitors
TargetsPhospholipase A2 group IIAArachidonate 5-lipoxygenase
Therapy Area/IndicationsArthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEli Lilly And Company
Active IndicationsN/A
Inactive IndicationsArthritis

Other Information

ATC CodeN/A
Related LinksN/A